8-K: Movano Health Faces Nasdaq Delisting Threat Over Delayed Filings

Movano Health received a Nasdaq notice for failing to timely file its quarterly report and is awaiting a panel decision on its compliance plan to avoid delisting.

Summary

• Received a notice from Nasdaq on August 21, 2025, for non-compliance with Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-Q for the quarter ended June 30, 2025.
• The Form 10-Q was due on August 14, 2025.
• Appealed a previously announced delisting determination at a Nasdaq Hearing Panel on August 19, 2025.
• Submitted a Compliance Plan to regain compliance with both the Filing Requirement and the $1.00 Minimum Bid Price requirement (Nasdaq Listing Rule 5550(a)(2)).
• Engaged RBSM LLP as the new independent registered public accounting firm on August 13, 2025, as part of the Compliance Plan.
• Awaiting the determination of the Nasdaq Hearing Panel regarding the appeal and compliance plan.

Sentiment

Score: 2

Explanation: The company faces significant immediate threats including potential delisting from Nasdaq due to non-compliance with filing requirements and minimum bid price. While a compliance plan has been submitted, the outcome is uncertain, indicating a highly negative short-term outlook.

Positives

• Submitted a comprehensive Compliance Plan to Nasdaq to address both the delayed filing and the minimum bid price requirements.
• Engaged a new independent registered public accounting firm, RBSM LLP, on August 13, 2025, which is a proactive step towards resolving the delayed filing issue.

Negatives

• Received a notice of non-compliance from Nasdaq for failing to timely file its Form 10-Q for the quarter ended June 30, 2025.
• The Form 10-Q was due on August 14, 2025, indicating a delay of at least seven days prior to the Nasdaq notice.
• Faces a previously announced delisting determination due to non-compliance with the $1.00 Minimum Bid Price requirement.
• There is no assurance that Nasdaq will grant a stay of suspension or that the company will successfully regain and maintain its listing.

Risks

• Nasdaq may not accept the company's compliance plan.
• Nasdaq may not grant an extension or the duration of any granted extension may be insufficient.
• Potential inability to meet Nasdaq's listing requirements.
• Uncertainties associated with the company's preparation of the delinquent filing.
• Possibility of additional delays in the filing of the delinquent Form 10-Q and other SEC filings.
• Risk of suspension of the company's securities from trading on the Nasdaq Capital Market.
• General risks and uncertainties described in the company's SEC reports, including Form 10-K and 10-Q.

Future Outlook

Movano Health has submitted a plan to regain compliance with Nasdaq's filing and minimum bid price requirements and is awaiting a determination from the Nasdaq Hearing Panel. There is no guarantee that a stay of suspension will be granted or that the company will successfully regain and maintain its Nasdaq listing.

Management Comments

• Submitted a plan to regain compliance with the Filing Requirement and the $1.00 Minimum Bid Price requirement.
• Awaiting the determination of the Panel and will be providing an update to the Panel as required.

Industry Context

This announcement is specific to Movano Health's operational and compliance challenges, rather than broader industry trends. However, timely financial reporting and maintaining listing standards are fundamental expectations across all publicly traded companies in the health technology and wearables sector, and failure to do so can severely impact investor confidence and market access.

Stakeholder Impact

• Shareholders: Significant negative impact due to the risk of delisting, which could severely limit liquidity and depress share price. Uncertainty regarding the company's future on a major exchange.
• Investors: Increased risk profile, potential loss of confidence, and difficulty in trading shares if delisted.
• Employees: Potential uncertainty regarding the company's stability and future operations.
• Customers/Suppliers: Indirect impact from potential loss of investor confidence or operational disruptions, though not directly addressed.

Next Steps

• Await the determination of the Nasdaq Hearing Panel regarding the appeal and compliance plan.
• Provide updates to the Nasdaq Hearing Panel as required.
• Execute the Compliance Plan if a stay of suspension is granted.
• Complete and file the delinquent Form 10-Q.

Key Dates

Recommendation

The immediate threat of delisting from Nasdaq due to both delayed financial reporting and failure to meet minimum bid price requirements presents an extremely high level of risk. While a compliance plan is in place, there is no assurance of its acceptance or the company's ability to regain compliance. This situation severely impairs investor confidence, liquidity, and the company's access to capital markets, making the stock highly speculative and warranting a strong sell recommendation.

Keywords

Movano Health, MOVE, Nasdaq, Delisting, Form 10-Q, SEC Filing, Compliance Plan, Minimum Bid Price, Financial Reporting, Corporate Governance, Wearables, Evie Ring